谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Rituximab Versus Obinutuzumab-Based First-Line Chemoimmunotherapy for Follicular Lymphoma-a Real-World Multicenter Retrospective Cohort Study.

Tamar Berger,Tzippy Shochat,Shlomzion Aumann,Boaz Nachmias,Neta Goldschmidt,Nurit Horesh,Reut Harel,Ariel Aviv,Ella Shmerts,Uri Abadi,Shai Shimony,Pia Raanani,Anat Gafter‑Gvili,Ronit Gurion

Annals of hematology（2023）

引用 0|浏览21
暂无评分
摘要
The GALLIUM study showed a progression-free survival advantage of 7
更多
查看译文
关键词
Follicular lymphoma (FL),Induction,Chemo-immunotherapy,Obinutuzumab,Rituximab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要